Navigation Links
Patient management: Quality of life and beyond
Date:12/12/2008

SAN ANTONIO - Breast cancer is a multifaceted disease requiring creative solutions for diagnosis, quality of life management and adjuvant therapies. Data presented at the CTRC-AACR San Antonio Breast Cancer Symposium explore these areas.


Hormone Supplements Reduce Death from Breast Cancer
Abstract #65, Sarah Marshall, M.A.

Although hormone supplements have been implicated in increased rates of breast cancer, they appear to mitigate the mortality risk of breast cancers that do develop. Compared with women who did not use hormone therapy, women who took estrogen-progestin were 63 percent less likely to die from breast cancer while those who took estrogen alone were 30 percent less likely.

Full release available/Complete data to be presented at the meeting.


Tamoxifen Tops Anastrazole for Quality of Life, but not Survival
Abstract #1136, Shozo Ohsumi, M.D., Ph.D.
Embargo: 5:30 p.m. CST, December 11, 2008

After one to four years of tamoxifen, switching to anastrozole improves disease-free survival by about 31 percent, but patients pay a price in quality of life measures. The difference in quality of life is significant enough that scientists say it should be considered, and may even be the deciding factor, when making a clinical decision about therapeutic strategy.

Full release available/Complete data to be presented at the meeting.


Letrozole following breast cancer surgery may provide survival benefit
Abstract #13, Alan Coates, M.D.
Embargo: 9:45 a.m. CST, December 11, 2008

Letrozole may improve overall survival in patients with primary breast cancer. A four-arm comparison study of letrozole and tamoxifen shows letrozole not only reduces recurrence, but may provide a 13 percent reduction in risk of death. Additionally, the study finds that using a sequence of tamoxifen and letrozole is not superior to letrozole alone. The sequence of letrozole followed by tamoxifen was closely similar to letrozole alone implying that patients can safely switch to tamoxifen after initial letrozole if required.

Complete data to be presented at the meeting.


Use of Written Forms Doubles Breast Cancer Detection Rate
Abstract #5012, William Goodson, M.D.

When clinicians used simple written forms to focus attention during clinical breast exams, the rate of breast mass detection from the previous year doubled without retraining clinicians, thus affirming the importance of clinician attentiveness. This finding, researchers say, can be applied to all aspects of medicine and undermines the need for intensive training, complicated techniques, and medical reimbursement codes to improve this simple, yet valuable procedure.

Complete data to be presented at the meeting.


'/>"/>

Contact: Jeremy Moore
Jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Related medicine news :

1. Risk Info for Breast Cancer Patients Too Confusing
2. Combo Therapy Helps Multiple Myeloma Patients
3. Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
4. Early stage, HER2-positive breast cancer patients at increased risk of recurrence
5. Patient Care Means Employee Care at Illinois Hospitals
6. 2 Markers Predict Survival Odds in Colon Cancer Patients
7. Hallmark Hall of Fame Collaboration with Patient Organization Equals Extraordinary Success
8. Nursing Data on Patient Safety in California Will Expand to Include Two Pacific Northwest States
9. Sanofi-aventis Partners with the African American Community in Baltimore to Increase Health Awareness, Access to Resources and Help Improve Patient Care
10. LegalView Reports That Skin Cancer Drug May Offer Treatment to Mesothelioma Patients
11. Michigan Governors Executive Order Budget Cuts Do Not Cut Payments to Medicaid Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified ... be personalized through a fitness app. The fitness app plans to fix the two major ... only offer a one size fits all type program , They don’t eliminate ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 , ... Thursday, July 7, 2016 , , , , LOCATION: , ... , , , , EXPERT PANELISTS:  , , , Frost ... Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh ... The global pharmaceutical industry is witnessing an exceptional era. Several ...
(Date:6/23/2016)... , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with ... Latin America . ... ... ... ...
(Date:6/23/2016)...  Guerbet announced today that it has been named ... . One of 12 suppliers to receive ... support of Premier members through exceptional local customer service ... to lower costs. ... outstanding customer service from Premier," says Massimo Carrara ...
Breaking Medicine Technology: